About us
History
Leaderships
Team
EU grants
Requests for Proposal
Sustainability – ESG
Bussines strategy
Quality policy
Virtual Tour
Services
Drug Substance Manufacturing
Fill & Finish
Gene to Vial: End-to-End Development
Process Development
Analytics
Cell Line Development & Banking
Science Hub
Science News
Resources
News & Events
Press releases
Events
Content to download
Investors
Corporate documents
Shareholders and shares
Periodic reports
Current reports
Sustainability reports
Corporate governance at Mabion
Financial data
For Investors
Calendar
Contact us
Contact form
Contact for investors
Contact for media
Careers
EN
Science News
Resources
Manufacturing
Why Europe is Becoming a Global Hub for Biologics Manufacturing
Biologics
,
Manufacturing
Upstream Development for High Yield Biologics Production
Biologics
,
Drug development
,
Manufacturing
End-to-End Manufacturing of Biosimilars – From Cell Line to Commercial Product
Biosimilars
,
Manufacturing
The Role of Downstream Development in Ensuring Biologic Product Purity and Quality
Drug product
,
Manufacturing
Aseptic Filling in Modern Pharmaceutical Manufacturing
Drug product
,
Manufacturing
Role of Stable Cell Line in Biopharmaceutical Manufacturing
Drug development
,
Drug product
,
Manufacturing
Time to Market Strategy – 5 CDMO Tactics to Speed Up Biologic Launches
Biologics
,
Drug development
,
Manufacturing
Navigating OOX Results: Effective Analysis and Management in CDMO Laboratories
Analytics
,
Manufacturing
,
Regulatory
Mammalian Cell Lines as a Platform for Protein Vaccine Production
Cell culture
,
Drug substance
,
Manufacturing
,
Proteins
,
Vaccines
Previous
1
2
3
Next